Kira Morin (@morink) header
Kira Morin (@morink) profile picture

Brain enthusiast, data nerd, advocate and lover of humanity #pwLC

Memphis, TN
Joined April 2009
Photo by Kira Morin (@morink)Photo by Kira Morin (@morink)Photo by Kira Morin (@morink)Photo by Kira Morin (@morink)Photo by Kira Morin (@morink)Photo by Kira Morin (@morink)
One planet. Thousands of lights. One message: People with ME/CFS need visibility. In just 4 days: over 3,500 lights from more than 50 countries across 6 continents. Add your light of solidarity! Please share. forward-with-mecfs.com/?lang… #MECFS #MillionsMissing
8
70
5
152
6,070
Kira Morin retweeted
And just like that, we have our first clinical trial and pharma partnership in the works! We’re teaming up with Prolong to take the drug they developed for stroke and see if it can help our patients with ME/CFS by increasing oxygen delivery and blood flow. Thanks to the 200TB of data @chroniclebioAI has amassed, combined with our AI engine, we are identifying patients that show hypoxia so we can focus this trial on them. This is really the promise of the company: understanding biology at such a deep level that we can match the exact right patients to the exact right drugs and massively increase the likelihood of success of trials. Going from company creation to first trial in less than two years is pretty cool, but there’s still a lot of work to be done to prove we can improve patients’ lives. One step at a time.
Today we are announcing our first clinical trial. We're joining forces with Prolong to evaluate a potential treatment for post exertional malaise (PEM) in #MECFS. Sanguinate is an investigational intravenous therapy designed to deliver oxygen to deprived tissues, support blood flow, and reduce inflammation. The planned multi-site Phase 2a trial will evaluate the drug in at least 40 patients with first dosing expected mid-2027. Most trials enroll patients based on symptoms alone, but recruitment for this study will leverage ChronicleBio's proprietary endotype intelligence platform to identify patients whose disease biology suggests they may be more likely to respond.  We are excited for our partnership with Prolong and grateful for the patient community that drives everything we do.  Read More: chroniclebio.com/news/chroni…
80
109
18
872
79,843
Kira Morin retweeted
Your chances of being able bodied your entire life are slim to none. It is always in your best interest to advocate for a more accessible world fr
26
10,440
117
54,172
483,160
Kira Morin retweeted
Amazing!!! Nasa just mapped the whole Ocean surface from space by using Gravity.
136
948
126
12,798
1,970,683
Kira Morin retweeted
I can’t believe we’re two months away from 2027 and the easiest way to save something as a PDF is still to lie to your computer and tell it you’re about to print it.
402
8,456
282
137,447
3,074,922
Kira Morin retweeted
Today, in collaboration with Anthropic, we’re excited to share rapid initial progress towards an antibody treatment for food allergy, which affects over 200 million people worldwide, discovered with the help of Claude. At Divergence Labs, we believe that AI can unlock the next generation of antibody therapeutics with more effective mechanisms than before. Such mechanisms are urgently needed in food allergy, which involve overcoming one of the tightest affinity protein pairs in immunology, IgE and its receptor FcεRI, on mast cells. Treatment with Xolair—the only approved antibody for food allergy—sequesters circulating IgE, but mast cells remain sensitized for weeks to months due to the extraordinarily slow dissociation of IgE from FcεRI. We envision a treatment that actively pulls IgE off of FcεRI, without waiting for natural dissociation. Like picking a lock, this requires the right combination of geometry and force. Our research team, working with Claude, ideated on mechanisms to accomplish this disruption, and converged on an antibody format with two arms with different functions and epitopes. Within one month, we designed, synthesized, and experimentally confirmed the biophysical function of the two arms, which we are now assembling into full therapeutic formats.
133
630
130
5,137
511,029
Mega cool. In my research heyday, I performed neurological stereotactic surgery on rats injecting tract tracers. Survival rate was only 40%…. AI > human undergrads 💯😂
Last night an AI agent performed brain surgery on a mouse. We gave it 19 gene therapy vectors in a spreadsheet, a mouse model of epilepsy, access to a motorize surgery rig with cameras and one goal: reduce seizures. It picked the drug. It picked the brain region. It derived the coordinates from three papers. Then it drove the stereotaxic arms into the brain and injected 250 nanolitres while watching the entry site through the rig camera for bleeding. A licensed vet gated every irreversible step and held a physical kill switch to stop the AI agent. Thread on what it decided, what it saw, and the moment it refused to let me override it. [Writing this on the spot out of excitement, but I've been 18hrs in front of my laptop coding and coordinating this, so keeping it brief and descriptive, more cohesive thoughts on this soon...]
1
71
As of today, level 2-3.
Levels of Autonomic Function Chart that is highly relevant in Long Covid, POTS, MECFS. Doctors do not tell you this at all. I recommend bringing to your doctor. I am between level 3 and level 4. #LongCovid #POTS #pwME #MECFS #Dysautonomia
3
243
Thread: Update on the Edogawa Protocol: I’m not doing it (for now).
1
2
2
9
959
8/If you’re considering similar treatments or want to know more about the testing above, I'll do my best to answer. Everyone's different, so what's helped me may not help you. Thank you to everyone who has followed along. If you’re sick too, I hope you find answers soon.
1
5
104
Kira Morin retweeted
At the Harvard/MIT Martinos Center, Dr. Mario Murakami and the VanElzakker lab are using ultrahigh-resolution 7T fMRI to understand how changes to cerebrospinal fluid (CSF) flow in people with Craniocervical Instability can produce a phenotype similar to that seen in ME/CFS and other neuroimmune conditions. The brain relies on cerebrospinal fluid to carry out metabolic waste that builds up during normal physiological processes, acting as a “garbage disposal,” as explained by Murakami. Changes to healthy CSF flow may result in the buildup of these metabolites in the brain. Said Murakami, “There is a compromised structure of CSF flow in CCI [patients] compared with healthy controls, which means that maybe this is part of the mechanisms which drive the symptoms—the brain fog, the pain, the fatigue, the autonomic dysfunction.”
5
48
7
149
8,196
Kira Morin retweeted
Scientists found a way to flush Alzheimer’s plaque out of the brain in minutes. Without any surgery and drugs. Your brain has a waste-clearance network called the glymphatic system. It flushes out toxic proteins and dead cells. But it only really activates during deep, slow-wave sleep. If you don't sleep, the trash piles up. Over time, that buildup leads to cognitive decline and Alzheimer's. Until today. Researchers just published a paper proving they can manually trigger this cleaning cycle. Without you ever going to sleep. They used 40.68 MHz ultrashort waves (USW) beamed non-invasively into the brain. Within 10 minutes, the brain's fluid flow rapidly accelerated. The waves artificially synchronized the neurons into a Delta state, the exact frequency of deep sleep. This forced the brain's water channels to open and start flushing out the system. They tested it on mice with traumatic brain injuries and Alzheimer's pathology. The brain swelling dropped. The toxic proteins were cleared out. Cognitive deficits actually improved. No surgery. No massive chemical interventions. Just a frequency.
596
7,687
793
32,034
1,480,125